2-FA Pellets – 60mg
€ 5,95
2-FA Pellets are a pressed-pellet research material associated with 2-fluoroamphetamine, a synthetic fluorinated amphetamine derivative featuring an ortho-position fluorine substituent on its aromatic ring. Raw Lab Chems identifies the material for controlled chemical characterization, chromatographic identification, positional-isomer differentiation, and analytical reference-oriented laboratory investigation. The supplied description includes purity, testing, and packaging claims that require batch-specific documentation before they can be considered verified.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
2-FA Pellets – 60mg
Product Overview
2-FA Pellets are described in the supplied information as a pressed-pellet laboratory research material associated with 2-fluoroamphetamine, also called ortho-fluoroamphetamine.
The compound belongs to the broader category of fluorinated amphetamine derivatives and substituted phenethylamines.
The product is identified by a nominal labeled pellet strength, but label information alone does not independently establish actual compound content, chemical identity, purity, or formulation uniformity.
Raw Lab Chems presents the material exclusively within a Research Use Only framework.
The supplied description identifies chemical characterization, chromatographic investigation, analytical method development, and positional-isomer differentiation as relevant research contexts.
These contexts are distinct from clinical, diagnostic, therapeutic, or consumer applications.
The source describes the material as laboratory-grade and refers to extensive quality-assurance practices. Those descriptions should be treated as supplier-provided claims until supported by documentation associated with the actual batch.
Chemical Identity & Classification
2-FA is the abbreviated name for 2-fluoroamphetamine, a synthetic fluorinated analog of amphetamine.
The compound is also known as ortho-fluoroamphetamine, reflecting the position of the fluorine substituent on the aromatic ring.
This structural feature distinguishes it from related positional isomers in which fluorine occupies a different location.
The supplied source identifies the freebase molecular formula as C9H12FN.
It also lists two possible CAS Registry Numbers, 1626-69-3 and 1716-60-5, without establishing which identifier corresponds to the actual material or its chemical form.
These identifiers should not be treated as interchangeable without independent verification.
The source states that the compound is often supplied as a hydrochloride salt, but it does not confirm the salt form of the actual pellet preparation.
Consequently, no specific salt identity is assigned to the supplied product.
The stated molecular-weight range is also dependent on the assumed chemical form and is not adopted as a verified product specification.
Researchers may consult PubChem for additional chemical-reference information, ensuring that any database record matches the exact substance, form, and identifier being investigated.
Chemical & Physical Characteristics
The supplied product is described as a solid pressed-pellet preparation.
The source characterizes the pellets as compact and generally off-white to light beige.
However, no product photograph, physical inspection record, or batch-specific appearance specification was supplied.
Accordingly, the stated appearance remains an unverified source description.
The material’s fluorinated aromatic structure is relevant to chemical classification and comparison with other substituted amphetamine derivatives.
The source also describes compatibility with several laboratory solvents, including ethanol, methanol, dimethyl sulfoxide, and acetonitrile.
No measured solubility values, validated solvent-compatibility data, or batch-specific extraction results accompanied these statements.
Solubility and analytical behavior should therefore be established experimentally when relevant to a particular laboratory investigation.
The source does not identify pellet binders, fillers, excipients, crystalline characteristics, or validated dissolution behavior.
Such formulation details may affect analytical interpretation and should not be inferred from the nominal chemical identity.
Purity & Analytical Verification
The supplied description refers to research-grade purity of at least 98% where supported by analytical verification.
However, no actual batch-specific purity result, Certificate of Analysis, chromatogram, spectrum, or independent laboratory report accompanied the source.
The stated purity threshold is therefore not independently verified for the material described here.
The source identifies HPLC, GC-MS, LC-MS/MS, and NMR spectroscopy as relevant analytical techniques.
These methods are commonly associated with chemical identification, chromatographic characterization, and structural investigation.
Nevertheless, naming a technique does not establish that it has been performed on the supplied product.
For analytical work involving fluorinated amphetamine derivatives, distinguishing positional isomers may be especially important.
Researchers should evaluate whether the selected method provides adequate chemical specificity for the exact substance under investigation.
A nominal pellet label, general purity claim, or chemical-class designation is not a substitute for batch-specific analytical evidence.
Quality Control & Batch Integrity
The supplied source claims that individual batches undergo independent laboratory verification and are supported by Certificates of Analysis.
It also describes batch tracking, impurity monitoring, and manufacturing conditions characterized as ISO-aligned.
No actual Certificate of Analysis, independent testing record, accreditation information, manufacturing audit, or quality-system documentation was provided.
These statements therefore remain unverified supplier claims.
Similarly, the source’s reference to ICH-aligned practices does not establish compliance with any specific guideline or validated manufacturing standard.
For reproducible analytical investigation, useful documentation may include supplier identification, batch number, sample description, analytical method, test results, and storage history.
Where a material is described as suitable for reference-standard work, researchers should distinguish ordinary catalog material from a certified reference material with established traceability and documented uncertainty.
The supplied information does not establish certified reference-material status.
Pellet uniformity, impurity limits, and analytical consistency should be assessed from actual supporting records rather than assumed from the product presentation.
Safety, Handling & Laboratory Precautions
2-Fluoroamphetamine is an amphetamine-derived substance requiring appropriate laboratory risk assessment and controlled handling.
Research personnel should consult applicable safety documentation and institutional procedures before receiving or examining the material.
Appropriate precautions may include access controls, protective equipment, contamination prevention, secure sample identification, and procedures for accidental exposure.
The pressed-pellet format should not be interpreted as evidence of pharmaceutical suitability or authorization for personal use.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Laboratory handling procedures should also account for the possibility that the stated chemical identity, purity, and formulation have not been independently confirmed.
Disposal should follow applicable institutional requirements and chemical-waste regulations.
Packaging, Labeling & Storage
The supplied source recommends storage in a cool, dry, low-humidity environment protected from light.
It additionally recommends refrigeration at 2–8°C.
No validated stability study, degradation dataset, or experimentally established shelf-life specification was provided to substantiate this temperature recommendation.
The source describes moisture-resistant and light-resistant packaging, including sealed pouch-style materials.
No packaging-validation records or actual shipment-condition data accompanied those statements.
Laboratory labels should clearly distinguish the named compound, the pellet presentation, and any available batch identifier.
Where chemical form or CAS identification remains uncertain, inventory records should preserve that uncertainty rather than present an unverified designation as confirmed.
Environmental conditions should be selected using available safety information, relevant stability evidence, and institutional laboratory requirements.
Intended Research Use & Market Positioning
The supplied scientific context places 2-FA within analytical investigation of fluorinated amphetamine derivatives, chemical identification, chromatographic profiling, and positional-isomer characterization.
Its ortho-fluorinated structure provides a chemical basis for comparison with related compounds containing different aromatic substitutions.
For comparative catalog research, Raw Lab Chems also lists 2-FMA Pellets and 2-FMA Capsules.
These listings concern a distinct fluorinated amphetamine derivative and should not be treated as analytically or chemically interchangeable with 2-FA.
The supplied 2-FA Pellets catalog reference identifies the product presentation discussed here.
These references provide chemical-catalog context rather than evidence of equivalent identity, purity, or analytical performance.
Ordering, Availability & Fulfillment
The supplied source describes worldwide shipping, discreet packaging, tracking, and protective transportation materials.
No current inventory record, carrier confirmation, destination-specific authorization, or verified shipment-performance documentation was provided.
Accordingly, no specific availability, delivery, customs-clearance, or transportation guarantee is asserted.
Because fluorinated amphetamine derivatives may be subject to controlled-substance or analog legislation, institutional acquisition and transfer require particular attention to applicable law.
Researchers and institutions should independently determine whether possession, importation, exportation, transportation, and laboratory investigation are authorized in their jurisdictions.
Research-only labeling does not establish an exemption from controlled-substance regulations.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
2-FA is an amphetamine-derived research substance whose legal classification may vary by jurisdiction.
Acquisition, possession, transfer, importation, exportation, storage, and laboratory investigation may be restricted or prohibited under applicable controlled-substance, analog, or other chemical regulations.
Researchers and institutions are responsible for verifying all relevant legal requirements and obtaining any necessary authorizations.
No medical approval, consumer-use authorization, universal legal status, or regulatory exemption is implied by this description.
You must be logged in to post a review.

Reviews
There are no reviews yet.